Table 1.
Groups | 1 | 3 | 2 | 4 |
---|---|---|---|---|
Patients (M/W) before matching | 74 (16/58) | 221 (101/120)** | 454 (76/378) | 748 (222/526)** |
DM SURG | DM No-SURG | No-DM SURG | No-DM No-SURG | |
---|---|---|---|---|
Patients (M/W) | 52 (15/37) | 127 (36/91) | 333 (78/255) | 554 (136/418) |
Age (years) | 49.9 ± 5.25 | 51.9 ± 8.61 | 39.2 ± 10.37 | 40.2 ± 12.03 |
BMI (kg/m2) | 43.0 ± 3.98 | 41.9 ± 6.31 | 41.1 ± 5.36 | 40.9 ± 7.31 |
Systolic BP (mmHg) | 142.0 ± 12.29 | 148.0 ± 22.46 | 134.9 ± 16.48 | 134.4 ± 16.74 |
Diastolic BP (mmHg) | 85.3 ± 5.95 | 85.9 ± 11.28 | 82.3 ± 10.41 | 82.8 ± 10.42 |
Heart rate (bpm) | 80.9 ± 4.15 | 77.4 ± 3.64 | 75.6 ± 4.46 | 70.4 ± 4.72 |
Arterial hypertension | 15 | 53 | 77 | 132 |
Creatinine (µmol/l) | 74.4 ± 21.95 | 77.3 ± 25.26 | 74.6 ± 16.14 | 76.7 ± 19.84 |
eGFR (ml/min/1.73 m2) | 88.8 ± 20.19 | 88.0 ± 24.87 | 92.1 ± 26.13 | 87.8 ± 18.67 |
BG (mg/dl) | 169.7 ± 60.56 | 185.3 ± 62.55 | 92.4 ± 12.69 | 94.7 ± 12.19 |
DM drug treatment | 6 | 27 | ||
HbA1c (%) | 7.2 ± 2.19 | 8.1 ± 1.88 | 5.7 ± 1.17 | 5.6 ± 1.25 |
Total cholesterol (mg/dl) | 218.7 ± 43.74 | 219.4 ± 55.33 | 210.4 ± 43.26 | 212.0 ± 98.31 |
HDL-cholesterol (mg/dl) | 50.3 ± 14.71 | 46.8 ± 13.46 | 51.1 ± 12.94 | 50.0 ± 15.10 |
LDL-cholesterol (mg/dl) | 147.6 ± 38.43 | 144.4 ± 45.23 | 136.0 ± 37.24 | 140.2 ± 99.26 |
Triglycerides (mg/dl) | 159.3 ± 80.06 | 208.8 ± 198.23 | 127.5 ± 70.62 | 135.3 ± 68.88 |
AST (U/l) | 30.9 ± 22.28 | 30.6 ± 22.30 | 22.8 ± 10.20 | 24.6 ± 12.44 |
ALT (U/l) | 42.3 ± 31.11 | 44.6 ± 44.93 | 31.2 ± 22.70 | 33.9 ± 22.67 |
Retinopathy | 1 | 7 | ||
CHD | 0 | 13* | 4 | 22* |
Mean ± SD or absolute frequencies
DM diabetes mellitus, SURG surgery, No-DM nondiabetic, No-SURG non-undergoing surgery, BP blood pressure, eGFR estimated glomerular filtration rate, FBG fasting blood glucose, CHD coronary heart disease
* p < 0.05 surgery versus no surgery; ** p < 0.001 surgery versus no-surgery